Comparative Effectiveness Research in Pediatric Rheumatic Diseases: Leveraging CA

Medicine & Life Sciences

1. Rheumatic Diseases 100%
2. Pediatrics 66%
3. Rheumatology 60%
4. Comparative Effectiveness Research 56%
5. Clinical Protocols 37%
6. Arthritis 32%
7. Registries 29%
8. Child 24%
9. Juvenile-onset scleroderma 17%
10. Public-Private Sector Partnerships 14%
11. Localized Scleroderma 13%
12. Research Personnel 13%
13. Consent Forms 12%
14. Delphi Technique 12%
15. Clinical Trials 12%
16. Dermatomyositis 11%
17. Rheumatologists 11%
18. Juvenile Arthritis 11%
19. Patient Reported Outcome Measures 10%
20. Research Ethics Committees 9%
21. Radiology 9%
22. Systemic Lupus Erythematosus 8%
23. Health Care Costs 8%
24. Sample Size 8%
25. Cost-Benefit Analysis 8%
26. Therapeutics 7%
27. Datasets 7%
28. Meta-Analysis 6%
29. Retrospective Studies 6%
30. Health Care Outcome Assessment 6%
31. Demography 6%
32. Quality of Life 6%
33. Prospective Studies 5%
34. Physicians 5%
35. Morbidity 5%